|Bid||0.00 x 0|
|Ask||0.00 x 0|
|Day's range||33.88 - 34.04|
|52-week range||19.45 - 34.39|
|Beta (5Y monthly)||0.72|
|PE ratio (TTM)||141.83|
|Forward dividend & yield||0.24 (0.69%)|
|Ex-dividend date||30 Mar 2023|
|1y target est||N/A|
An analyst had a fresh new take on the company's prospects, and it wasn't all that positive.
Shares in the Anglo-Swedish drugs giant fell 0.4% in afternoon trade in London.
Rare is a story this unequivocally positive. A "practice-changing" drug developed by AstraZeneca and Japanese pharma giant Daiichi Sankyo has...